We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Depression Confirmed as Osteoporosis Risk Factor

By LabMedica International staff writers
Posted on 22 Nov 2009
Print article
A recently published review article summarized studies relating clinical depression and osteoporosis and concluded that a clear connection exists between the two.

Osteoporosis is the most widespread degenerative disease in the developed world, afflicting about 33% of women and 20% of men in the over 50 age group. In an endeavor to better understand risk factors for the syndrome, investigators at the Hebrew University of Jerusalem (Israel) reviewed research articles that related loss of bone mass, which characterizes osteoporosis, to evidence of clinical depression.

Their findings, based on the evaluation of 23 research projects conducted in eight countries that compared bone density among 2,327 people suffering from depression against 21,141 nondepressed individuals were published in the September 2009 issue of the journal Biological Psychiatry. The results showed that overall, depressed individuals displayed lower bone mass density than nondepressed subjects. The association between depression and bone mass density was similar in the spine, hip, and forearm. It was stronger in women than in men, and in premenopausal than postmenopausal women. Only women individually diagnosed for major depression by a psychiatrist displayed significantly lower bone mass density; women diagnosed by self-rating questionnaires did not. Depressed subjects had increased urinary levels of bone breakdown markers as compared to their nondepressed counterparts.

Based on these findings the authors concluded that, "All individuals psychiatrically diagnosed with major depression are at risk for developing osteoporosis, with depressed young women showing the highest risk. These patients should be periodically evaluated for progression of bone loss and signs of osteoporosis, allowing the use of antiosteoporotic prophylactic and therapeutic treatments."

Related Links:
Hebrew University of Jerusalem



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Automated Blood Typing System
IH-500 NEXT
New
Flow Cytometer
BF – 710
New
Thyroid ELISA Kit
AESKULISA a-TPO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.